Keywords: corixa/gsk, initiatesph, trial, her-2/neu, breast, cancer, usa-based

Corixa/GSK initiatesPh I trial of HER-2/neu in breast cancer

Article | 09 June 2003

Print This

USA-based Corixa has initiated a Phase I clinical trial, in collaboration with GlaxoSmithKline Biologicals, to test the safety and immune ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in